Xi Chen

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 29, 2021
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.

Shukui Qin, Feng Bi, Shanzhi Gu

Pageof 1

Frequent Collaborators

1 joint publications

Shukui Qin

1 joint publications

Feng Bi

1 joint publications

Li Xu

1 joint publications

Xiaoyu Wen